Cinnal-f

Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa (r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large German registry

Infertility Treatments Resulting in Twin Pregnancy Does It Increase the Risk for Future Childhood Malignancy

Intraovarian Injection of Recombinant Human Follicle-Stimulating Hormone for Luteal-Phase Ovarian Stimulation during Oocyte Retrieval Is Effective inWomen with Impending Ovarian Failure and Diminished Ovarian Reserve

Relationship Between Number of Oocytes Retrieved and Embryo Euploidy Rate in Controlled Ovarian Stimulation Cycles

The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization

The time interval between oocyte retrieval and frozen embryo transfer does not impact reproductive outcomes

Cinnal-f Monograph